Biotech stocks are not for the faint of heart. These highly volatile equities can see stomach-churning price swings, driven by how their treatments fare in Food & Drug Administration clinical trials and real-world applications.
Picking the right biotech stocks means the difference between treading water and impressive outperformance. To help you achieve the latter for your portfolio, Forbes Advisor has identified nine of the best biotech stocks. These companies have growing revenue and strong forward growth expectations.